Know Cancer

or
forgot password
  • cancer clinical trials in cincinnati, OH

  • Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
    Oncology Hematology Care
    Cincinnati, Ohio 45242
    Metastatic Melanoma
    N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Neuroblastoma
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer
    Oncology Hematology Care, Inc
    Cincinnati, Ohio 45242
    Metastatic Breast Cancer
    A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer
    Location #41
    Cincinnati, Ohio 45219
    Metastatic Breast Cancer
    Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC
    Oncology Hematology Care
    Cincinnati, Ohio 45242
    Non-Small-Cell Lung Cancer
    Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer
    Oncology Hematology Care, Inc.
    Cincinnati, Ohio 45219
    Breast Cancer
    Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Adrenocortical Carcinoma, Gastrointestinal Carcinoid Tumor, Kidney Cancer, Neuroblastoma, Retinoblastoma, Sarcoma
    Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Lung Cancer
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Epilepsy, Tuberous Sclerosis Complex
    Immunotherapy Study for Surgically Resected Pancreatic Cancer
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Pancreatic Cancer
    A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
    Oncology Hematology Care
    Cincinnati, Ohio 45242
    Extensive-Stage Small Cell Lung Cancer
    A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
    Cincinnati Children's Hospital Medical Center Cincinnati Children's Hosp
    Cincinnati, Ohio 45229-3039
    Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    Good Samaritan Hospital - Cincinnati

    Trial Locations
    Good Samaritan Hospital - Cincinnati
    Bethesda North Hospital
    University of Cincinnati
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
    Investigational Site Number 840004
    Cincinnati, Ohio 45267-0542
    Hematological Malignancy
    A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cincinnati, Ohio 45267
    Head and Neck Neoplasms
    Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Childhood Low-grade Cerebellar Astrocytoma, Childhood Low-grade Cerebral Astrocytoma, Childhood Mixed Glioma, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Oligodendroglioma, Recurrent Childhood Visual Pathway and Hypothalamic Glioma, Recurrent Childhood Visual Pathway Glioma
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Cervical Cancer
    Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Hemophagocytic Lymphohistiocytosis
    Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
    Jewish Hospital BMT Program
    Cincinnati, Ohio 45236
    Chronic GVHD
    Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)
    Jewish Hospital BMT Program
    Cincinnati, Ohio 45236
    Multiple Myeloma
    Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    Oncology Hematology Care
    Cincinnati, Ohio 45242
    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
    Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
    Cincinnati Childrens' Hospital
    Cincinnati, Ohio 45229
    Sickle Cell Disease, Vaso-occlusive Crisis, Pain Crisis
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Kidney Cancer
    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
    Good Samaritan Hospital - Cincinnati

    Trial Locations
    Good Samaritan Hospital - Cincinnati
    University of Cincinnati
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Solar Radiation-related Skin Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Ceprotin Treatment Registry
    Cancer and Blood Diseases Institute
    Cincinnati, Ohio 45229
    Severe Congenital Protein C Deficiency
    Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector
    Cincinnati Children's Medical Center
    Cincinnati, Ohio 45267
    Severe Combined Immunodeficiency
    Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Neuroma, Acoustic
    Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Cancer
    Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    The Christ Hospital
    Cincinnati, Ohio 45219
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
    Investigational Site Number 840007
    Cincinnati, Ohio 45267-0542
    Neoplasm Malignant
    Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Unspecified Childhood Solid Tumor, Protocol Specific
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Leukemia
    A Multicenter, Open-label Study of CMX001 Treatment of Serious Diseases or Conditions Caused by dsDNA Viruses
    Cincinnati Childrens Hospital
    Cincinnati, Ohio 45229
    Male or Female Patients With a Serious or Immediately Life-threatening, Disease or Condition Caused by CMV, ADV, HSV, VAVC, VARV or, Monkeypox Viruses(s) Who Have a Life Expectancy of ≥ 2 Weeks and for, Whom no Comparable or Satisfactory Alternative Therapy is Available
    Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)
    The Jewish Hospital
    Cincinnati, Ohio 45236
    Acute Myeloid Leukemia (AML)
    Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Childhood Hepatoblastoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Malignant Germ Cell Tumor, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    First in Man Study of SAR566658 Administered Every 3 Weeks in Patients With DS6-positive and Refractory Solid Tumors
    Investigational Site Number 840002
    Cincinnati, Ohio 45267-0542
    Neoplasm Malignant
    Study of RAD001 (Everolimus) for Children With NF1 and Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Glioma
    Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
    The Christ Hospital Cancer Center Research
    Cincinnati, Ohio 45219
    Non-Squamous Non-Small Cell Lung Cancer
    INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unspecified Childhood Solid Tumor, Protocol Specific
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Good Samaritan Hospital - Cincinnati

    Trial Locations
    Good Samaritan Hospital - Cincinnati
    University of Cincinnati
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Neuroblastoma, Rhabdomyosarcoma, Lymphoma, Wilm's Tumor, Ewing's Sarcoma
    A Study in Second Line Metastatic Colorectal Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cincinnati, Ohio 45267
    Colorectal Cancer
    Natural History Study of SCID Disorders
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    SCID, Leaky SCID, Omenn Syndrome, Reticular Dysgenesis, ADA Deficiency, XSCID